Company: OTSA
Filing Date: 2025-07-07
Form Type: F-1/A
Source: 0001213900-25-061733
Chunk: 34

Company: OTSAW Ltd
Filing Date: 2025-07-07
Form: F-1/A
Chunk 34
---
 are in the research and development stage of upgrading our proprietary software technology, the ANS, from Version 2 to Version 3. We intend for Version 3 to be a commercial software solution that will provide a foundational outdoor autonomy capability for third -partyAMR products, AMR frameworks or hardware platforms, under the product brand “Odyssey”. Furthermore, as part of our joint venture with Swisslog Healthcare Holding AG (“Swisslog Healthcare”), we are developing the next -generationof TransCar solutions for hospitals intralogistics. We are in the research and development stage of upgrading Swisslog Healthcare’s TransCar system to the next generation of TransCar, Transcar 5.0, by utilizing our core software technologies and robotics autonomy and mobility expertise. 17 Because we account for research and development costs as operating expenses, these expenditures will adversely affect our earnings in the future. Our research and development efforts and investments may not be successful, and our new products and services may not achieve market acceptance, create any additional revenue or become profitable if customers do not perceive our product and service offerings as providing significant new functionality or value. We may not achieve material revenue from our new products, services, and technologies. Our competitors may surpass us in technological innovation, hindering our ability to commercialize new and competitive products that meet the needs and demands of the market in a timely manner or at all, which consequently may adversely impact our operating results as well as our reputation. Our limited operating history makes it difficult to evaluate our business, prospects, and future viability, and may increase the risk of your investment. Any evaluation of our business and our prospects must be considered in light of our limited operating history and the risks and uncertainties encountered by companies in our stage of development. Further, our industry is characterized by rapid technological change, changing customer needs, evolving industry standards and frequent introduction of new products and services. We encountered, and expect to continue to encounter, risks and uncertainties frequently experienced by early -stagecompanies in rapidly changing markets, including risks relating to our ability to, among other things: •generate sufficient revenue to achieve profitability; •hire, integrate and retain qualified professional and technical talent, including key members of management; •access additional capital when required and on reasonable terms; •achieve or manage growth in our operations, continue to make significant investments in research, development, production, marketing and sales; •successfully obtain, maintain, protect and enforce our intellectual property and defend against claims of intellectual property infringement, misappropriation or other violations; •build and maintain the